AstraZeneca expects Covid vaccine result by year-end if trials resume
Kamada Rises 5% On Initial Phase 1/2 Trial Results For Covid Treatment
Sanofi's Covid-19 Vaccine Could Cost Under €10 Per Shot, Says Senior Exec
Moderna Slips 4% Amid Report Of Slowdown In Covid-19 Trial Enrollment
The Economy Continues To Unravel Despite All Stimulus Measures
Widespread Covid-19 vaccinations not expected until mid-2021, WHO says
Steroids cut COVID-19 death rates, but not for everyone – here’s who benefits and who doesn’t
Sanofi, GSK To Kick Off Human Trials Of Covid-19 Candidate
GSK and Vir take COVID-19 antibody therapy into clinic
84% Of CFOs Say Stocks Are Overvalued
J&J to start mid-stage coronavirus vaccine trials in three European countries
VBI Vaccines' COVID-19 Vaccine Could Be a Game Changer, Says 5-Star Analyst
Novavax CEO expects filing for Covid-19 vaccine approval in December
Carnival’s Princess Cancels Early 2021 Cruises Due to Covid-19
Trump Administration picks McKesson for coronavirus vaccine distribution
"Financially Devastated" - 83% Of NYC Restaurants Unable To Pay July Rent
Roku Stock at $208 a Share? This Analyst Thinks It's Possible
Only 42% Say They Will Submit To COVID-19 Vaccine, New Poll Finds
Etsy Crushes 2Q Revenue Expectations; Roth Raises Stock To Buy
"They Just Got Zucked" - Instagram Releases TikTok "Ripoff" As Microsoft, ByteDance Talk Turkey
How COVID-19 could impact travel for years to come
Sanofi, GSK Nearing EU Supply Deal For 300M Covid-19 Vaccine Doses
Pinterest Pops 36% After Quarterly Revenue Beat Fueled By Ad Recovery
This Week in Apps: A guide to the US antitrust case against Apple, Microsoft in talks to buy TikTok
Walmart (WMT) Stock Could Stay Grounded for Now, Says 5-Star Analyst
Emirates to cover COVID-19 medical costs for customers in bid to boost travel confidence
Johnson & Johnson Starts First Human Trials For Its Covid-19 Candidate
MLB trade rumors and news: Marlins’ season paused due to coronavirus outbreak
Kodak Soars After Government Loan To End China Medical Supply Chain Reliance
Emergent Signs $174M Manufacturing Deal For AstraZeneca’s Covid-19 Candidate